208 related articles for article (PubMed ID: 32468269)
1. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G; Altieri B; Albertelli M; Dotto A; Modica R; Barrea L; Fanciulli G; Feola T; Baldelli R; Ruggeri RM; Gallo M; Guarnotta V; Malandrino P; Messina E; Venneri MA; Giannetta E; Ferone D; Colao A; Faggiano A;
Endocrine; 2020 Aug; 69(2):441-450. PubMed ID: 32468269
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China.
Fu M; Yu L; Yang L; Chen Y; Chen X; Hu Q; Sun H
Front Endocrinol (Lausanne); 2022; 13():885895. PubMed ID: 36004340
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
[TBL] [Abstract][Full Text] [Related]
4. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.
Valente R; Hayes AJ; Haugvik SP; Hedenström P; Siuka D; Korsæth E; Kämmerer D; Robinson SM; Maisonneuve P; Delle Fave G; Lindkvist B; Capurso G
Endocr Relat Cancer; 2017 Aug; 24(8):405-414. PubMed ID: 28566532
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.
Gao Y; Gao H; Wang G; Yin L; Xu W; Peng Y; Wu J; Jiang K; Miao Y
Sci Rep; 2018 May; 8(1):7271. PubMed ID: 29739948
[TBL] [Abstract][Full Text] [Related]
6. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
[TBL] [Abstract][Full Text] [Related]
7. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%).
Liu Y; Wang J; Zhou H; Wei Z; Wang J; Wang Z; Chen X
BMC Gastroenterol; 2023 Dec; 23(1):436. PubMed ID: 38087239
[TBL] [Abstract][Full Text] [Related]
8. Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms.
Zhuge X; Wang Y; Chen X; Guo C
Front Endocrinol (Lausanne); 2020; 11():615082. PubMed ID: 33424776
[TBL] [Abstract][Full Text] [Related]
9. The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study.
Wang C; Lin T; Chen X; Cui W; Guo C; Wang Z; Chen X
Cancer Biomark; 2023; 36(4):279-286. PubMed ID: 36938727
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
11. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
[TBL] [Abstract][Full Text] [Related]
12. A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study.
Zhang X; Song J; Liu P; Mazid MA; Lu L; Shang Y; Wei Y; Gong P; Ma L
BMC Endocr Disord; 2018 Oct; 18(1):73. PubMed ID: 30340569
[TBL] [Abstract][Full Text] [Related]
13. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
Primavesi F; Klieser E; Cardini B; Marsoner K; Fröschl U; Thalhammer S; Fischer I; Hauer A; Urbas R; Kiesslich T; Neureiter D; Zitt M; Klug R; Wundsam H; Sellner F; Karner J; Függer R; Cakar-Beck F; Kornprat P; Öfner D; Stättner S;
Eur J Surg Oncol; 2019 Feb; 45(2):198-206. PubMed ID: 30262324
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading.
Li WX; Miao F; Xu XQ; Zhang J; Wu ZY; Chen KM; Yan FH; Lin XZ
Acad Radiol; 2021 Feb; 28(2):208-216. PubMed ID: 32111466
[TBL] [Abstract][Full Text] [Related]
15. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
[TBL] [Abstract][Full Text] [Related]
17. Adrenocorticotropic Hormone-Producing Pancreatic Neuroendocrine Neoplasms: A Systematic Review.
Wu Y; Xiong G; Zhang H; Wang M; Zhu F; Qin R
Endocr Pract; 2021 Feb; 27(2):152-157. PubMed ID: 33616046
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome.
Milanetto AC; Gais Zürcher AL; David A; Fassan M; Pasquali C
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902627
[TBL] [Abstract][Full Text] [Related]
19. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
[TBL] [Abstract][Full Text] [Related]
20. lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling.
Ji M; Yao Y; Liu A; Shi L; Chen D; Tang L; Yang G; Liang X; Peng J; Shao C
Endocr Relat Cancer; 2019 Jul; 26(7):643-658. PubMed ID: 31117050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
